| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,118 |
19,097 |
$3.02M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,567 |
9,536 |
$2.20M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,565 |
2,840 |
$2.09M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,824 |
1,718 |
$1.35M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,876 |
6,362 |
$795K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,499 |
1,409 |
$687K |
| 80053 |
Comprehensive metabolic panel |
12,850 |
10,935 |
$629K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,685 |
3,102 |
$596K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,717 |
2,240 |
$546K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
9,096 |
3,482 |
$513K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,229 |
2,492 |
$441K |
| G0378 |
Hospital observation service, per hour |
1,013 |
510 |
$415K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,628 |
1,562 |
$372K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,988 |
2,024 |
$309K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,275 |
4,092 |
$301K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,826 |
4,304 |
$294K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,659 |
3,386 |
$292K |
| 71046 |
Radiologic examination, chest; 2 views |
2,079 |
2,003 |
$256K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,470 |
12,108 |
$243K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,168 |
1,918 |
$218K |
| 71045 |
Radiologic examination, chest; single view |
2,824 |
2,588 |
$190K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,127 |
3,928 |
$172K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,123 |
1,010 |
$166K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,745 |
2,623 |
$158K |
| 84484 |
|
3,171 |
2,648 |
$149K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
225 |
210 |
$149K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
410 |
374 |
$148K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,627 |
3,000 |
$134K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
342 |
335 |
$133K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,960 |
2,621 |
$130K |
| 36415 |
Collection of venous blood by venipuncture |
14,356 |
11,945 |
$129K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,707 |
793 |
$106K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
326 |
315 |
$101K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,044 |
2,832 |
$96K |
| 80061 |
Lipid panel |
2,003 |
1,961 |
$91K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,700 |
3,239 |
$90K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,472 |
3,664 |
$87K |
| 73630 |
|
536 |
494 |
$76K |
| 81001 |
|
3,637 |
3,348 |
$75K |
| 73610 |
|
493 |
469 |
$74K |
| 83690 |
|
3,011 |
2,696 |
$72K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,579 |
1,501 |
$68K |
| 97161 |
|
1,104 |
1,046 |
$67K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,747 |
1,487 |
$66K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
763 |
679 |
$64K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
78 |
75 |
$62K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,165 |
2,110 |
$62K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,094 |
1,964 |
$60K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,816 |
2,661 |
$58K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
793 |
653 |
$56K |
| 83880 |
|
776 |
702 |
$55K |
| 84703 |
|
1,804 |
1,680 |
$52K |
| 81025 |
|
1,974 |
1,843 |
$51K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
737 |
713 |
$50K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
695 |
677 |
$48K |
| 85379 |
|
1,001 |
954 |
$45K |
| 86140 |
|
1,390 |
1,248 |
$45K |
| 87081 |
|
1,570 |
1,525 |
$43K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
438 |
418 |
$43K |
| 76830 |
Ultrasound, transvaginal |
167 |
161 |
$41K |
| 83735 |
|
1,930 |
1,286 |
$39K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
233 |
207 |
$38K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
963 |
930 |
$38K |
| 81003 |
|
2,504 |
2,376 |
$37K |
| 86780 |
|
685 |
668 |
$37K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
363 |
273 |
$36K |
| 97803 |
|
418 |
346 |
$35K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,929 |
1,713 |
$35K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,813 |
1,518 |
$34K |
| 87077 |
|
1,452 |
1,382 |
$31K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,615 |
1,429 |
$28K |
| 72100 |
|
199 |
195 |
$28K |
| 87400 |
|
395 |
378 |
$28K |
| 73562 |
|
190 |
181 |
$28K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,612 |
1,485 |
$27K |
| 87186 |
|
596 |
562 |
$25K |
| 96376 |
|
761 |
545 |
$25K |
| 82962 |
|
2,149 |
1,792 |
$23K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
393 |
380 |
$22K |
| 86803 |
|
269 |
265 |
$22K |
| 85027 |
|
1,524 |
1,389 |
$21K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
216 |
215 |
$21K |
| 85610 |
|
1,710 |
1,428 |
$18K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,018 |
858 |
$18K |
| 87340 |
|
445 |
431 |
$17K |
| J2704 |
Injection, propofol, 10 mg |
798 |
655 |
$16K |
| 76801 |
|
58 |
53 |
$16K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
834 |
774 |
$16K |
| 80050 |
General health panel |
115 |
113 |
$15K |
| 86885 |
|
571 |
530 |
$15K |
| 73030 |
|
100 |
92 |
$14K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
247 |
233 |
$14K |
| 84439 |
|
471 |
458 |
$13K |
| J3490 |
Unclassified drugs |
481 |
401 |
$13K |
| J7050 |
Infusion, normal saline solution, 250 cc |
969 |
568 |
$13K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
12 |
12 |
$13K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
149 |
146 |
$12K |
| 74018 |
|
94 |
83 |
$12K |
| 82728 |
|
282 |
271 |
$12K |
| 87430 |
|
274 |
263 |
$11K |
| 85652 |
|
588 |
541 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
353 |
347 |
$11K |
| 97802 |
|
84 |
80 |
$11K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
504 |
408 |
$10K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
75 |
60 |
$10K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
95 |
88 |
$9K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
36 |
26 |
$9K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
12 |
12 |
$8K |
| 73130 |
|
65 |
61 |
$8K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
83 |
83 |
$8K |
| 84145 |
|
102 |
90 |
$8K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
567 |
512 |
$8K |
| 94762 |
|
99 |
60 |
$8K |
| 99215 |
Prolong outpt/office vis |
100 |
77 |
$7K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,861 |
1,761 |
$7K |
| 84702 |
|
136 |
106 |
$7K |
| 97113 |
|
67 |
27 |
$7K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
39 |
39 |
$7K |
| 83605 |
|
247 |
229 |
$6K |
| 87070 |
|
241 |
230 |
$6K |
| 59025 |
Fetal non-stress test |
32 |
13 |
$6K |
| 73110 |
|
45 |
38 |
$6K |
| 97535 |
Self-care/home management training, each 15 minutes |
81 |
53 |
$6K |
| 86850 |
|
115 |
102 |
$5K |
| 96127 |
|
649 |
623 |
$5K |
| 82550 |
|
231 |
196 |
$5K |
| 80143 |
|
56 |
50 |
$5K |
| 86900 |
|
269 |
247 |
$5K |
| 80179 |
|
55 |
50 |
$5K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
20 |
13 |
$5K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
101 |
96 |
$5K |
| 83540 |
|
147 |
143 |
$4K |
| 81002 |
|
296 |
284 |
$4K |
| 80076 |
|
84 |
78 |
$4K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
13 |
12 |
$4K |
| 85651 |
|
190 |
180 |
$3K |
| 86901 |
|
268 |
247 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
242 |
234 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
143 |
138 |
$3K |
| 82570 |
|
176 |
150 |
$3K |
| 85007 |
|
455 |
393 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
289 |
287 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
153 |
149 |
$2K |
| 97162 |
|
38 |
38 |
$2K |
| 86762 |
|
52 |
52 |
$2K |
| 82670 |
|
29 |
28 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
90 |
72 |
$2K |
| 81015 |
|
266 |
256 |
$2K |
| 91320 |
|
18 |
18 |
$2K |
| 90686 |
|
156 |
156 |
$2K |
| 82607 |
|
52 |
50 |
$2K |
| 94664 |
|
40 |
40 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
110 |
87 |
$2K |
| 80320 |
|
207 |
177 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
89 |
69 |
$2K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
67 |
66 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
46 |
45 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
39 |
39 |
$2K |
| 36416 |
|
225 |
220 |
$2K |
| 84402 |
|
24 |
24 |
$1K |
| 87040 |
|
37 |
24 |
$1K |
| 84403 |
|
57 |
54 |
$1K |
| 83655 |
|
83 |
81 |
$1K |
| 90715 |
|
73 |
71 |
$1K |
| 82150 |
|
38 |
38 |
$1K |
| 84100 |
|
54 |
40 |
$1K |
| 90656 |
|
220 |
220 |
$1K |
| 87205 |
|
39 |
36 |
$1K |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
16 |
15 |
$981.43 |
| 83550 |
|
77 |
74 |
$931.19 |
| 97165 |
|
18 |
16 |
$891.29 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
29 |
27 |
$811.78 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
35 |
30 |
$754.87 |
| 82950 |
|
26 |
26 |
$682.26 |
| 90480 |
|
39 |
39 |
$673.10 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$550.44 |
| 80047 |
|
15 |
14 |
$508.34 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
24 |
24 |
$446.46 |
| 87806 |
|
221 |
216 |
$378.78 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
15 |
12 |
$282.63 |
| 85014 |
|
40 |
33 |
$275.08 |
| 85018 |
|
58 |
56 |
$250.73 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
90 |
87 |
$234.23 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
60 |
55 |
$220.56 |
| 85730 |
|
15 |
14 |
$167.63 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
326 |
291 |
$158.76 |
| 90671 |
|
12 |
12 |
$137.83 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
13 |
13 |
$137.60 |
| 90461 |
|
15 |
15 |
$124.82 |
| 87147 |
|
12 |
12 |
$108.30 |
| 99177 |
|
40 |
40 |
$96.81 |
| 80329 |
|
34 |
28 |
$91.46 |
| 11721 |
|
12 |
12 |
$78.33 |
| 80332 |
|
32 |
26 |
$63.78 |
| G0659 |
Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes |
55 |
51 |
$0.00 |
| A9270 |
Non-covered item or service |
1,995 |
1,286 |
$-1769.38 |